Degli Esposti, L. et al. 2021. Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs. Reumatismo. 73, 1 (Apr. 2021), 5–14. DOI:https://doi.org/10.4081/reumatismo.2021.1329.